Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azasetron administration timing and fractionation for prevention of postoperative nausea and vomiting after gynecological laparoscopy
ChiCTR2300076786Phase 4Completed
- Sponsor
- Dalian Municipal Central Hospital
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of azasetron in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Dalian Municipal Central Hospital. Primary endpoints: Incidence of nausea and vomiting, Nausea and vomiting frequency and 1 more. Started Oct 2023; status: completed.
02
Drugs
azasetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2300076786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076786.